#GLP1 #PharmaTrends #WeightLossDrugs #NovoNordisk #EliLilly #Ozempic #Wegovy #Mounjaro #Zepbound #MetabolicHealth #HealthcareInnovation #Biopharma To view or add a comment, sign in GENERIC SEMAGLUTIDE IS COMING TO CANADA BUT ITS NOT A FREE PASS FOR PATIENT ACCESS Yes, Sandoz slashing the cost of semaglutide is a massive win
Start with one or two targeted additions based on your specific needs
According to the Medicines and Healthcare products Regulatory Agency (MHRA) approved Summary of Product Characteristics (SmPC), musculoskeletal pain is not listed amongst the recognised adverse effects of Ozempic
Thus, the development of additional therapeutic drugs including antidiabetics or IR interventions with beneficial effects against cognitive impairment and Alzheimers disease carry promising future application potentials
In order to be eligible, you cant be using those benefits to cover a portion of medication costs
Not approved for human consumption